Key regions: Japan, India, Italy, Brazil, South Korea
Anti-Hypertensive Drugs, also known as high blood pressure medication, is a growing market in Togo. This medication is used to treat high blood pressure, a common health condition that affects many Togolese citizens.
Customer preferences: Togolese citizens are becoming increasingly aware of the importance of maintaining good health. As a result, there is a growing demand for anti-hypertensive drugs in the country. Many Togolese people are also becoming more health-conscious and are taking steps to prevent high blood pressure by adopting healthier lifestyles.
Trends in the market: The market for anti-hypertensive drugs in Togo is expected to continue to grow in the coming years. This growth is being driven by several factors, including an aging population, increasing urbanization, and a rise in lifestyle-related diseases. Additionally, the Togolese government is taking steps to improve healthcare access and quality, which is likely to further increase demand for anti-hypertensive drugs.
Local special circumstances: One of the unique factors affecting the anti-hypertensive drug market in Togo is the prevalence of traditional medicine. Many Togolese people still rely on traditional medicine to treat their health conditions, including high blood pressure. However, as access to healthcare improves and awareness of the benefits of modern medicine grows, more people are likely to turn to anti-hypertensive drugs to manage their condition.
Underlying macroeconomic factors: Togo is a low-income country with a relatively small economy. However, the country has experienced steady economic growth in recent years, which is likely to continue in the coming years. This growth is being driven by several factors, including improvements in infrastructure, increased foreign investment, and a growing service sector. As the economy continues to grow, more Togolese citizens are likely to have access to healthcare and be able to afford anti-hypertensive drugs.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
